# JCAD — Peer-reviewed, evidence-based

> Peer-reviewed dermatology journal with evidence-based clinical and aesthetic content. (iPhone/iPad app by Matrix Medical Communications.)

- Source: https://appshunter.io/ios/app/jcad/id630827146 (this page in markdown: same URL + `.md`)
- Developer: [Matrix Medical Communications](https://appshunter.io/developer/991783027)
- Category: Medical, Health & Fitness
- Price: Free
- Rating: 5.00/5 from 1 App Store ratings · 1 written reviews indexed
- Age rating: 17+
- Requires: iOS 11.0 · 87 MB
- Languages: American English
- Released: 2013-04-09
- Data updated: 2026-06-06
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/jcad/id630827146/reviews.md

## What is JCAD?

Journal of Clinical and Aesthetic Dermatology (JCAD) is a peer-reviewed publication that has already become an important addition to the field of dermatology. Under the expert editorial leadership of James Del Rosso, DO, and Philip Werschler, MD, JCAD provides dermatologists with up-to-date, evidence-based information that can be applied to their daily practices. JCAD offers its readers original research, practical discussion on the latest research, comprehensive reviews, didactic case reports, and provocative commentaries on contemporary topics relating to both clinical and aesthetic dermatology, written by key opinion leaders as well as practicing clinicians who are “in the trenches,” providing vital balance to the research-rich literature that is already available. JCAD is the official journal of the American Cutaneous Oncology Society and the American Acne and Rosacea Society. JCAD is indexed on PubMed Central, Scopus, EMBASE, and CINAHL Plus.

## Key features

- Peer-reviewed publication
- Evidence-based information
- Original research
- Comprehensive reviews
- Expert editorial leadership
- Indexed on major databases

## Recent user reviews (1 of 1)

All indexed reviews: https://appshunter.io/ios/app/jcad/id630827146/reviews.md

### 5/5 — Nice App

*2019-11-29*

Good app for JCAD and a responsive staff.

## Frequently asked questions about JCAD

### What kind of content does JCAD offer?

JCAD offers its readers original research, practical discussions on the latest research, comprehensive reviews, didactic case reports, and commentaries on contemporary topics relating to both clinical and aesthetic dermatology.

### Who is the editorial leadership for JCAD?

JCAD is under the expert editorial leadership of James Del Rosso, DO, and Philip Werschler, MD, providing a balanced perspective from key opinion leaders and practicing clinicians.

### Is JCAD indexed in major medical databases?

Yes, JCAD is indexed on PubMed Central, Scopus, EMBASE, and CINAHL Plus, ensuring its content is widely accessible and discoverable by researchers and clinicians.

### What societies is JCAD the official journal for?

JCAD is the official journal of the American Cutaneous Oncology Society and the American Acne and Rosacea Society, reflecting its focus on key areas within dermatology.

### What devices is JCAD available on?

JCAD is available on iPhone, iPad, and iPod, making it accessible to a wide range of Apple device users.

### What is the age rating for JCAD?

JCAD has an age rating of 17+, indicating its content is intended for mature audiences with a professional interest in dermatology.

### How often is JCAD updated?

The latest version of JCAD was updated on 2025-06-10, suggesting regular updates to ensure content is current and the app remains functional.

### Does JCAD have ads?

No, JCAD does not contain advertisements, providing an uninterrupted reading experience for its users.

## Version history (last 5 releases)

### 7.2.1 — 2025-06-10

Bug fixes and optimizations for the latest version of iOS.

### 7.1.5 — 2024-05-22

Bug fixes and optimizations for the latest version of iOS.

### 7.0.21 — 2023-02-28

- New design to unify the desktop and mobile experience.

- All previously downloaded issues will need to be re-downloaded with this major update.

- New Menu: Allows quick access to all views in the app from top left toolbar Menu.

- Bug fixes and optimizations for the latest versions of iOS.

### 7.0.16 — 2022-04-06

- New design to unify the desktop and mobile experience.

- All previously downloaded issues will need to be re-downloaded with this major update.

- New Menu: Allows quick access to all views in the app from top left toolbar Menu.

- Bug fixes and optimizations for the latest versions of iOS.

### 7.0.15 — 2022-03-18

- New design to unify the desktop and mobile experience.

- All previously downloaded issues will need to be re-downloaded with this major update.

- New Menu: Allows quick access to all views in the app from top left toolbar Menu.

- Bug fixes and optimizations for the latest versions of iOS.

## Apps similar to JCAD

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [DermaCompass](https://appshunter.io/ios/app/dermacompass/id1124314488) | 5.0 (2) | Free | Medical |
| [Fitzpatrick's Color Atlas](https://appshunter.io/ios/app/fitzpatricks-color-atlas/id1317018164) | 4.5 (30) | Free | Medical |
| [Skin Infections and Treatments](https://appshunter.io/ios/app/skin-infections-and-treatments/id1472957044) | — | $1.99 | Medical |
| [Dermcam](https://appshunter.io/ios/app/dermcam/id958327023) | 5.0 (1) | Free | Medical |
| [ESDR](https://appshunter.io/ios/app/esdr/id1582474463) | — | Free | Medical |
| [Skin Therapy Letter](https://appshunter.io/ios/app/skin-therapy-letter/id398648893) | 1.0 (1) | Free | Medical |

## More apps by Matrix Medical Communications

- [Bariatric Times](https://appshunter.io/ios/app/bariatric-times/id496064747)
- [ICNS](https://appshunter.io/ios/app/icns/id850566372)

All apps by Matrix Medical Communications: https://appshunter.io/developer/991783027

## Related topics

[jcad](https://appshunter.io/ios/topics/jcad)

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-06.*
